The North America liposome drug delivery market is expected to reach US$ 2,735.64 million by 2027 from US$ 1,390.53 million in 2019; it is estimated to grow at a CAGR of 9% from 2019 to 2027.
The growth of the market is attributed to some key driving factors such as high incidence of chronic diseases amongst the population, an upsurge in need for non-invasive drug delivery solutions, increasing investments in R&D for pharmaceutical companies. However, high expense involved in the development of drug delivery systems is expected to obstruct the growth of the market to a certain extent during the forecast years
Liposomes are small sphere-shaped artificial vesicles synthesized from cholesterol and phospholipids. They have multiple layers and a diameter range of 0.01 to 5.0 um. They also have hydrophilic and hydrophobic properties which help liposomes to encapsulate hydrophobic and hydrophilic drugs to be delivered to targeted body site. Liposomes provide an assured system for targeted drug delivery and thereby is the factor influencing the Liposome Drug Delivery market size growth. Liposomes are widely used for enclosing all types of drug molecules such as acyclovir, chloroquine diphosphate, paclitaxel, tropicamide, and cyclosporine. Liposomes are used as a drug carrier for drug therapy for many diseases since they are biodegradable and biocompatible. Also, they have many therapeutic properties like anticancer drugs, genetic materials, proteins, vaccines, macromolecules, and thus can be encapsulated in liposomes.
The pharmaceutical and biotechnology companies are exploring alternative compositions with cholesterol as well as new techniques such as nanotechnology to improve the stability and drug release profiles with the help of encapsulation and other techniques. They are using liposomes for the generation of extracellular vesicles by targeted cells.
Manufacturers in the liposome drug delivery market are ramping up their R&D activities to unlock new lipid compositions and strategies that help to optimize the drug transport and stability of liposomes. Similar experiments for innovative liposome fabrication are likely to offer growth opportunities for the market players to attain a significant position and grow in the liposome drug delivery market—new development lipid composition for stability and optimization of drugs.
Based on product, the liposome drug delivery market is segmented into liposomal doxorubicin, liposomal paclitaxel, liposomal amphotericin B, others. The liposomal doxorubicin segment held the largest share of the market in 2019, whereas the liposomal amphotericin B segment is anticipated to register the highest CAGR in the market during the forecast period.
Based on technology, the liposome drug delivery market has been segmented into stealth liposome technology, non-PEGylated liposome technology, depofoam liposome technology. The stealth liposome technology segment held the largest share of the market in 2019, and continued to register the highest CAGR in the market during the forecast period.
Based on application, the liposome drug delivery market has been segmented into fungal diseases, cancer therapy, pain management, viral vaccines, and photodynamic therapy. The cancer therapy segment held the largest share of the market in 2019, and continued to register the highest CAGR in the market during the forecast period.
North America Liposome Drug Delivery Market revenue and forecast to 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
North America LIPOSOME DRUG DELIVERY MARKET SEGMENTATION
By Product
- Liposomal Doxorubicin
- Liposomal Paclitaxel
- Liposomal Amphotericin B
- Others
By Technology
- Stealth Liposome Technology
- Non-PEGylated Liposome Technology
- DepoFoam Liposome Technology
- Lysolipid Thermally Sensitive Liposome (LTSL) Technology
By Application
- Fungal Diseases
- Cancer Therapy
- Pain Management
- Viral Vaccines
- Photodynamic Therapy
Companies Mentioned
-- ASTELLAS PHARMA INC.
- JOHNSON AND JOHNSON SERVICES, INC.
- LUYE PHARMA GROUP
- TAKEDA PHARMACEUTICAL COMPANY LIMITED
- NOVARTIS AG
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product type, Technology, Application, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Liposome Drug Delivery Market – By Product
1.3.2 North America Liposome Drug Delivery Market – By Technology
1.3.3 North America Liposome Drug Delivery Market – By Application
1.3.4 North America Liposome Drug Delivery Market – By Geography
2. North America Liposome Drug Delivery Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Liposome Drug Delivery Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Liposome Drug Delivery Market - North America PEST Analysis
4.3 Expert Opinion
5. North America Liposome Drug Delivery Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising prevalence of Chronic Diseases
5.1.2 Growing Demand for Non-Invasive Drug Delivery Devices
5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies
5.2 Market Restraints
5.2.1 High Cost Involved in Development of Drug Delivery Systems
5.3 Market Opportunities
5.3.1 Development of New Lipid Composition for Stability and Optimization of Drugs
5.4 Future Trends
5.4.1 Increasing Popularity of Liposomes in Drug Delivery
5.5 Impact Analysis
6. Liposome Drug Delivery Market – North America Analysis
6.1 North America Liposome Drug Delivery Market Revenue Forecasts and Analysis
7. North America Liposome Drug Delivery Market Analysis and Forecasts To 2027 – By Product Overview
7.1 North America Liposome Drug Delivery Market, By Product Type 2019 & 2027 (%)
7.1.1 North America Liposome Drug Delivery Market Revenue and Forecasts to 2027, By Product Type (US$ Mn)
7.2 Liposomal Doxurubicin
7.2.1 Overview
7.2.2 North America Liposome Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
7.3 Liposomal Paclitaxel
7.3.1 North America Liposomal Paclitaxel Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Liposomal Amphotericin B
7.4.1 overview
7.4.2 North America Liposomal Amphotericin B forecast and market revenue
7.5 Others
7.5.1 overview
7.5.2 North America Other Liposome Drug Delivery Market overview and forecast to 2027
8. North America Liposome Drug Delivery Market – By Technology
8.1 Overview
8.2 North America Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)
8.3 Stealth Liposome Technology
8.3.1 Overview
8.3.2 North America Stealth Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Non-PEGylated Liposome Technology
8.4.1 Overview
8.4.2 North America Non-PEGylated Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.5 DepoFoam Liposome Technology
8.5.1 Overview
8.5.2 North America DepoFoam Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Lysolipid Thermally Sensitive Liposome (LTSL) Technology
8.6.1 Overview
8.6.2 North America Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9. North America Liposome Drug Delivery Market – By Application
9.1 Overview
9.2 North America Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)
9.3 Fungal Diseases
9.3.1 Overview
9.3.2 Fungal Diseases: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Cancer Therapy
9.4.1 Overview
9.4.2 Cancer Therapy: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Pain Management
9.5.1 Overview
9.5.2 Pain Management: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.6 Viral Vaccine
9.6.1 Overview
9.6.2 Viral Vaccine: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.7 Photodynamic Therapy
9.7.1 Overview
9.7.2 Photodynamic Therapy: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
10. North America Liposome Drug Delivery Market – Geographic Analysis
10.1 North America: Liposome Drug Delivery Market
10.1.1 Overview
10.1.2 North America: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.4 North America Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.5 North America Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.6 North America: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
10.1.7 US: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 US Skin aesthetic devices market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 US Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.8 Canada: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Canada Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Canada Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.9 Mexico: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 Mexico Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
11. Impact Of COVID-19 Pandemic On North America Liposome Drug Delivery Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 Takeda Pharmaceutical Company Limited
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.3 Novartis AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.5 Luye Pharma Group
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Johnson & Johnson Services, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Ipsen Pharma
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Word Index
LIST OF TABLES
Table 1. R&D Investments by major pharmaceutical companies
Table 2. North America Liposome Drug Delivery Market Revenue and Forecasts To 2027, By Product Type (US$ Mn)
Table 3. North America Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 4. North America Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 5. North America Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 6. US Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 7. US Skin aesthetic devices market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 8. US Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 10. Canada Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 11. Canada Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 12. Mexico Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 15. List of Abbreviation
LIST OF FIGURES
Figure 1. Liposome Drug Delivery Market Segmentation
Figure 2. North America Liposome Drug Delivery Segmentation : By Region
Figure 3. North America Liposome Drug Delivery Market Overview;
Figure 4. Others Segment Held Largest Share of Product Type in Liposome Drug Delivery Market
Figure 5. US is Expected to Show Remarkable Growth During the Forecast Period.
Figure 6. Liposome Drug Delivery Market - North America PEST Analysis
Figure 7. North America Liposome Drug Delivery Market Impact Analysis of Driver and Restraints
Figure 8. North America Liposome Drug Delivery Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. North America Liposome Drug Deliverys Market, By Product Type 2019 & 2027 (%)
Figure 10. North America Liposomal Doxurubicin Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. North America Liposomal Paclitaxel Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. North America Liposomal Amphotericin B market revenue and forecast to 2027
Figure 13. North America Other Liposome Drug Delivery Market overview and forecast to 2027
Figure 14. North America Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)
Figure 15. North America Stealth Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. North America Non-PEGylated Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. North America DepoFoam Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. North America Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. North America Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)
Figure 20. Fungal Diseases: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Cancer Therapy: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Pain Management: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Viral Vaccine: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Photodynamic Therapy: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. North America: Liposome Drug Delivery Market, by Key Country – Revenue (2019) (USD Million)
Figure 26. North America Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
Figure 27. North America: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
Figure 28. US: Liposome Drug Delivery market – Revenue and Forecast to 2027 (USD Million)
Figure 29. Canada: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Mexico: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Impact of COVID-19 Pandemic In North American Country Markets
The List of Companies - North America Liposome Drug Delivery Market
- Takeda pharmaceutical company
- Novartis AG
- Ipsen pharma
- Celsion Inc
- Luye pharma group
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to North America Liposome Drug Delivery Market
Sep 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Sep 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Sep 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Sep 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Sep 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)